Quality of life is a major concern of patients when they are choosing treatment for prostate cancer. Our prostate cancer panel led by Mike Scott is talking to Dr. Paul Schellhammer, a prostate cancer survivor himself, about treatment outcomes and post treatment quality of life, from his own experience as a patient and 40+ years of treating prostate cancer patients.
Dr. Paul Schellhammer
Immunotherapy Advances in Multiple Myeloma with Dr. Saad Usmani
Recent years have seen the emergence of immunotherapy as a leading form of treatment for multiple myeloma. New strategies as monoclonal antibody therapies, antibody-drug conjugates, immune checkpoint therapy, adoptive cell therapies such as natural killer cells, marrow infiltrating lymphocytes, dendritic cells, CAR T cell therapies and cancer vaccines represent the basis for next generation myeloma therapies. We are talking to Dr. Saad Usmani of Levine Cancer Institute / Carolinas Healthcare System about the latest advances in immunotherapy for multiple myeloma.
Dr. Saad Usmani
Developments in Personalized Medicine and New Options in Breast Cancer Treatmentwith Dr. Jame Abraham
In this era of personalized medicine the standard "one dose fits all" approach to cancer care has been ineffective leading to treatment failures. Personalized medicine is a new healthcare paradigm that allows physicians to choose treatment methodology optimally based on person's genetic or protein profiles. Our breast cancer panel is talking to Dr. Jame Abraham of Cleveland Clinic to learn about the developments in personalized medicine in breast cancer treatment. The panel will also discuss research in this field and new options available for breast cancer treatment. Panelists
Dr. Jame Abraham
For any of the talks dial-in to 718-664-6574 to participate and ask a question LIVE On-Air! Only 50 callers permitted at one time so HURRY!
The Axiom-2 mission successfully launched on May 21, 2023 and we are proud to be a part of this historic mission supporting it’s pre-flight and post-flight data collection with the TrialX xPAND app. The xPAND team…
The Axiom-2 mission is scheduled to launch on May 17, 2023 and pre-flight and post-flight data collection will be supported by the TrialX xPAND app. Our xPAND team is working tirelessly to ensure that the crew…
🚀 iConnect powers the RECOVER study TrialX iConnect is proud to support RECOVER (Researching COVID to Enhance Recovery), a nationwide initiative dedicated to understanding, treating, and preventing Long COVID. Our award winning patient recruitment management system will help…